Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$1.27B |
| 2 |
SNDK
Sandisk
SNDK
|
+$674M |
| 3 |
Credo Technology Group
CRDO
|
+$476M |
| 4 |
NBIS
Nebius Group N.V.
NBIS
|
+$452M |
| 5 |
Vertiv
VRT
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.98B |
| 2 |
Amazon
AMZN
|
+$1.25B |
| 3 |
Shopify
SHOP
|
+$1.08B |
| 4 |
Edwards Lifesciences
EW
|
+$1.07B |
| 5 |
Microsoft
MSFT
|
+$630M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 43.11% |
| 2 | Communication Services | 13.94% |
| 3 | Consumer Discretionary | 10.64% |
| 4 | Industrials | 9.08% |
| 5 | Healthcare | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Sonida Senior Living
SNDA
$1.8B
| $16.9M | 0.01% |
+414,541
| New | +$14.8M |
|
352
Neurogene
NGNE
$732M
| $16.3M | 0.01% |
518,582
-9,103
| -2% | -$251K |
|
|
CBRS
353
Cerebras Systems
CBRS
$42.5B
| $16.2M | 0.01% |
+73,182
| New | +$17.2M |
|
354
Mirion Technologies
MIR
$3.5B
| $15.9M | 0.01% |
887,170
-55,526
| -6% | -$1.03M |
|
355
MongoDB
MDB
$35.9B
| $15.8M | 0.01% |
46,944
+11,302
| +32% | +$3.39M |
|
356
Enliven Therapeutics
ELVN
$4.24B
| $15.7M | 0.01% |
309,219
+39
| +0% | +$1.66K |
|
357
Diamondback Energy
FANG
$55.4B
| $15.6M | 0.01% |
88,812
+255
| +0.3% | +$49.5K |
|
358
Halliburton
HAL
$30.1B
| $15.4M | 0.01% |
+454,552
| New | +$17.8M |
|
359
Palo Alto Networks
PANW
$303B
| $15.4M | 0.01% |
45,094
-3,246
| -7% | -$743K |
|
360
FIGS
FIGS
$2.56B
| $15.3M | 0.01% |
1,495,672
+94,458
| +7% | +$1.24M |
|
361
LPL Financial
LPLA
$29.2B
| $15.2M | 0.01% |
53,967
-81,254
| -60% | -$24.4M |
|
362
Impinj
PI
$5.2B
| $15.1M | 0.01% |
105,639
-3,243
| -3% | -$423K |
|
363
IonQ
IONQ
$15.9B
| $15.1M | 0.01% |
283,465
+261,060
| +1,165% | +$13.2M |
|
|
MAIR
364
Madison Air Solutions
MAIR
$13.2B
| $14.8M | 0.01% |
+379,121
| New | +$14.8M |
|
365
Adaptive Biotechnologies
ADPT
$4.02B
| $14.7M | 0.01% |
686,195
-66,878
| -9% | -$1.02M |
|
|
DPC
366
DPC Holdings PLC
DPC
$6.59B
| $14.7M | 0.01% |
+299,546
| New | +$14.6M |
|
367
Tyra Biosciences
TYRA
$1.49B
| $14.4M | 0.01% |
450,964
-181,468
| -29% | -$6M |
|
368
Herc Holdings
HRI
$5.03B
| $14.3M | 0.01% |
99,670
-5,404
| -5% | -$697K |
|
369
Western Midstream Partners
WES
$20B
| $13.7M | 0.01% |
313,367
-6,048
| -2% | -$260K |
|
370
Hess Midstream
HESM
$5.08B
| $13.6M | 0.01% |
360,782
-6,963
| -2% | -$268K |
|
371
Analog Devices
ADI
$175B
| $13.1M | 0.01% |
32,910
-62,218
| -65% | -$24.6M |
|
372
Rigetti Computing
RGTI
$5.2B
| $12.9M | 0.01% |
+667,806
| New | +$12.9M |
|
373
Rezolute
RZLT
$445M
| $12.8M | 0.01% |
2,459,308
-979,573
| -28% | -$3.64M |
|
374
Kinetik
KNTK
$4.33B
| $12.6M | 0.01% |
261,559
-5,048
| -2% | -$241K |
|
375
Xenon Pharmaceuticals
XENE
$5.81B
| $12.6M | 0.01% |
208,060
-1,110,754
| -84% | -$61.7M |
|
Similar funds
Jennison Associates's Q2 2026 Portfolio in Review
As of Q2 2026, Jennison Associates held 641 positions worth $167B, up 15% from $145B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Jennison Associates withdrew a net $6.22B in Q2 2026, closing 74 positions and reducing 282 holdings. Its most notable exit was Gilead Sciences, an estimated $176M position sold in full.
By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 39% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Jennison Associates opened a new position in SpaceX worth $1.27B.
- Jennison Associates's largest Q2 2026 buy was SpaceX: 7,448,891 shares worth $1.27B.
- Jennison Associates added most to Credo Technology Group in Q2 2026, an estimated $476M increase.
- Jennison Associates's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.98B.
- Jennison Associates fully exited Gilead Sciences in Q2 2026, selling an estimated $176M.
- Jennison Associates's ten largest holdings make up 45% of its $167B portfolio in Q2 2026.
- Jennison Associates opened 79 new positions and closed 74 in Q2 2026.
- Jennison Associates's portfolio value rose 15% quarter-over-quarter to $167B.
Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.